These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9145595)

  • 1. Resistance of Vibrio cholerae 01 to nalidixic acid.
    Jesudason MV; Saaya R
    Indian J Med Res; 1997 Apr; 105():153-4. PubMed ID: 9145595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental resistance of Vibrio cholerae el tor to nalidixic acid and fluoroquinolones].
    Ryzhko IV; Tsuraeva RI; Lomov IuM; Shut'ko AG; Mishan'kin BN; Koroleva NS; Samokhodkina ED; Shcherbaniuk AI
    Antibiot Khimioter; 2000; 45(9):7-12. PubMed ID: 11057367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India.
    Krishna BV; Patil AB; Chandrasekhar MR
    Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):224-6. PubMed ID: 16246383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.
    Vijayalakshmi N; Rao RS; Badrinath S
    Epidemiol Infect; 1997 Aug; 119(1):25-8. PubMed ID: 9287939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolone susceptibility of Vibrio cholerae O1 & O139 isolates from Vellore.
    Jesudason MV; Balaji V; Thomson CJ
    Indian J Med Res; 2002 Sep; 116():96-8. PubMed ID: 12619447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.
    Das S; Gupta S
    J Health Popul Nutr; 2005 Mar; 23(1):44-51. PubMed ID: 15884751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of nalidixic acid resistant Vibrio cholerae O-1 in Karachi.
    Mahmood A
    J Pak Med Assoc; 1999 Nov; 49(11):286. PubMed ID: 10647244
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quinolone resistance in Salmonella enterica].
    Seral C; López L; Castillo FJ; Clavel A; Rubio MC
    Rev Esp Quimioter; 1998 Mar; 11(1):43-6. PubMed ID: 9795288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008.
    Ranjbar M; Rahmani E; Nooriamiri A; Gholami H; Golmohamadi A; Barati H; Rajabifar D; Barati S; Sabet MS; Zamiri A; Haghighi S; Taifehashemi P; Nojomi M
    Trop Doct; 2010 Oct; 40(4):214-6. PubMed ID: 20709810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.
    Khan WA; Saha D; Ahmed S; Salam MA; Bennish ML
    PLoS One; 2015; 10(8):e0134921. PubMed ID: 26271050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
    Panhotra BR; Saxena AK; Al-Mulhim K
    Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of V. cholerae strains isolated in Bombay.
    Saraswathi K; Deodhar LP
    J Postgrad Med; 1990 Jul; 36(3):128-30. PubMed ID: 2102910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trend of antibiotic resistance of Vibrio cholerae strains from East Delhi.
    Das S; Saha R; Kaur IR
    Indian J Med Res; 2008 May; 127(5):478-82. PubMed ID: 18653912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of shigella to nalidixic acid & fluorinated quinolones.
    Thirunarayanan MA; Jesudason MV; John TJ
    Indian J Med Res; 1993 Nov; 97():239-41. PubMed ID: 8144205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serovar, biotype, phage type, toxigenicity & antibiotic susceptibility patterns of Vibrio cholerae isolated during two consecutive cholera seasons (1989-90) in Calcutta.
    Ramamurthy T; Pal A; Bhattacharya MK; Bhattacharya SK; Chowdhury AS; Takeda Y; Takeda T; Pal SC; Nair GB
    Indian J Med Res; 1992 May; 95():125-9. PubMed ID: 1506061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of cholera caused by Vibrio cholerae 01 intermediately resistant to norfloxacin at Malda, West Bengal.
    Bhattacharya MK; Ghosh S; Mukhopadhyay AK; Deb A; Bhattacharya SK
    J Indian Med Assoc; 2000 Jul; 98(7):389-90. PubMed ID: 11143861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with virulence and survival in environmental and clinical isolates of Vibrio cholerae O1 and non O1 in Romania.
    Israil A; Balotescu C; Bucurenci N; Năcescu N; Cedru C; Popa C; Ciufecu C
    Roum Arch Microbiol Immunol; 2003; 62(3-4):155-77. PubMed ID: 16008141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal].
    Heurtin-Le Corre C; Donnio PY; Bonnier M; Travert MF; Lacourt A; Avril JL
    Pathol Biol (Paris); 1998 Oct; 46(8):587-90. PubMed ID: 9871929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.